As of April 16, 2025, Ovid Therapeutics (OVID) has a market cap of $20.356 million USD. According to our data, Ovid Therapeutics is ranked No.8549 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $20.36 M |
-69.31%
|
Dec 31, 2024 | $66.32 M |
-70.99%
|
Dec 29, 2023 | $0.23 B |
73.12%
|
Dec 30, 2022 | $0.13 B |
-42.06%
|
Dec 31, 2021 | $0.23 B |
38.96%
|
Dec 31, 2020 | $0.16 B |
-44.34%
|
Dec 31, 2019 | $0.29 B |
71.49%
|
Dec 31, 2018 | $0.17 B |
-75.48%
|
Dec 29, 2017 | $0.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Marinus Pharmaceuticals
MRNS
|
$30.37 M |
0.028 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Agenus
AGEN
|
$42.77 M |
-0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Amicus Therapeutics
FOLD
|
$2.12 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
Market Cap | = | OVID Stock Price | * | OVID Shares Outstanding |
= | $0.29 | * | 71.08 M | |
= | $20.36 M |